DOCSLIB.ORG

ABC1: Connecting Yellow Tonsils, Neuropathy, and Very Low HDL

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
ABC1: Connecting Yellow Tonsils, Neuropathy, and Very Low HDL ABC1: connecting yellow tonsils, neuropathy, and very low HDL Helen H. Hobbs, Daniel J. Rader J Clin Invest. 1999;104(8):1015-1017. https://doi.org/10.1172/JCI8509. Commentary In 1960, the most common surgical procedure performed on children was tonsillectomy. During one such routine operation, an astute physician recognized that the tonsils of his 5-year-old patient from Tangier Island were anything but ordinary (1). The tonsils were strikingly large, lobulated, and lemon-colored. The tonsils of the patient’s sister were similarly abnormal in appearance and had a 50- to 100-fold elevated content of cholesteryl ester. The siblings also shared another remarkable trait: both had extremely low plasma levels of HDL cholesterol (HDL-C). These children were the index cases of Tangier disease, a genetic disorder characterized by an abnormal plasma lipoprotein profile — virtual absence of HDL-C, reduced levels of LDL cholesterol (LDL-C) with mildly or moderately elevated triglycerides, and a variety of seemingly disparate clinical findings, such as hepatosplenomegaly and peripheral neuropathy (2). The multifaceted manifestations of this disorder have inspired (and frustrated) more clinicians and scientists than there are patients with the disease. A breakthrough in our understanding of this enigmatic disease came recently when 3 groups identified the underlying molecular defect to be mutations in the ATP binding cassette transporter 1 (ABC1) gene (3–5). The report by Lawn et al. in this issue of the JCI extends these findings and provides a further functional characterization of the ABC1 transporter (6). These discoveries, which explain some of the […] Find the latest version: https://jci.me/8509/pdf ABC1: connecting yellow tonsils, Commentary neuropathy, and very low HDL See related article in this issue, pages R25–R31. Helen H. Hobbs1 and Daniel J. Rader2 1Departments of Internal Medicine and Molecular Genetics, University of Texas Southwestern Medical Center at Dallas, Dallas, Texas 75229, USA 2Departments of Internal Medicine and Pathology and Laboratory Medicine, University of Pennsylvania, Philadelphia, Pennsylvania 19104, USA Address correspondence to: Helen H. Hobbs, Department of Molecular Genetics, University of Texas Southwestern Medical Center at Dallas, 5323 Harry Hines Boulevard, Dallas, Texas 75229, USA. Phone: (214) 648-6724; Fax: (214) 648-7539; E-mail: [email protected]. In 1960, the most common surgical pro- arily conserved transmembrane pro- HDL (10). The full complement of cedure performed on children was ton- teins that transport a wide variety of substrates transported by ABC1 has sillectomy. During one such routine substrates, including ions, drugs, pep- not been identified, and it is possible operation, an astute physician recog- tides, and lipids, across cell mem- that some of the variability in the clin- nized that the tonsils of his 5-year-old branes (7). Mutations in other family ical manifestations of this disease is patient from Tangier Island were any- members cause a variety of genetic dis- due to mutation-specific differences thing but ordinary (1). The tonsils were orders, such as cystic fibrosis, intra- in substrate specificity. strikingly large, lobulated, and lemon- hepatic cholestasis, macular degener- Yellow/orange tonsils. What does Tang- colored. The tonsils of the patient’s sister ation, peroxisomal dysfunction, and ier disease teach us about the function were similarly abnormal in appearance immunodeficiency syndromes (7). of ABC1 and the importance of facili- and had a 50- to 100-fold elevated con- The first clue that ABC1 participated tated cholesterol efflux in human tent of cholesteryl ester. The siblings also in lipid metabolism came with the physiology? Despite near-ubiquitous shared another remarkable trait: both observation by Schmitz and col- expression of ABC1 (8), the cholesterol had extremely low plasma levels of HDL leagues that ABC1 expression rose accumulation in Tangier disease cholesterol (HDL-C). These children when the cholesterol content of appears to be restricted primarily to were the index cases of Tangier disease, a macrophages was increased (8). In an macrophages and to other cells of the genetic disorder characterized by an independent study using expression reticuloendothelial system. This sug- abnormal plasma lipoprotein profile — microarrays, Lawn et al. identified the gests that other cell types are better virtual absence of HDL-C, reduced levels ABC1 mRNA as an upregulated tran- able to control lipid entry and may not of LDL cholesterol (LDL-C) with mildly script in cholesterol-loaded be as dependent on facilitated efflux. or moderately elevated triglycerides, and macrophages (6). Macrophages rou- The hallmark yellow and/or orange a variety of seemingly disparate clinical tinely ingest large amounts of choles- discoloration of the tonsils, adenoids, findings, such as hepatosplenomegaly terol in the form of cellular membrane and colonic reticuloendothelial cells in and peripheral neuropathy (2). The mul- debris and aggregated lipoproteins, this disease may be due to the accu- tifaceted manifestations of this disorder and lack the ability to downregulate mulation in these cells of lipophilic have inspired (and frustrated) more cli- cholesterol uptake in response to cho- compounds such as vitamin E and nicians and scientists than there are lesterol loading (9). Consequently, retinyl esters (yellow) and carotenoids patients with the disease. macrophages are heavily dependent (orange). This feature of the disease A breakthrough in our understanding on cholesterol efflux (predominantly now raises the possibility that ABC1 is of this enigmatic disease came recently through transfer to HDL) to prevent also responsible for transporting when 3 groups identified the underlying accumulation of lipids. Thus, it might excess fat-soluble vitamins out of molecular defect to be mutations in the be anticipated that proteins that par- macrophages. ATP binding cassette transporter 1 ticipate in cholesterol efflux, such as Neuropathy. In patients with Tangier (ABC1) gene (3–5). The report by Lawn ABC1, would be increased in choles- disease, lipids also accumulate within et al. in this issue of the JCI extends terol-laden macrophages. The current Schwann cells, which synthesize and these findings and provides a further finding of Lawn et al. that ABC1 is maintain the myelin sheaths of functional characterization of the ABC1 located on the cell surface suggests peripheral nerves. The most debilitat- transporter (6). These discoveries, which that this transporter may actually ing feature of the disease is neuropa- explain some of the variable clinical physically participate in the hand-off thy, which affects approximately 50% manifestations of Tangier disease, will of cholesterol from cells to plasma of Tangier patients (2). Two major provide new insights not only into the HDL (6). This finding dovetails nicely types of neurological syndromes are physiology and cell biology of lipid with the previous observation that observed: (a) a syringomyelia-like dis- metabolism, but also into neurobiology Tangier fibroblasts have a greatly order, with progressive loss of sensory and possibly even atherosclerosis. reduced capacity to donate cellular and motor function in the upper ABC1 and cholesterol efflux. ABC1 cholesterol (and phospholipids) to body; and (b) a peripheral neuropathy, belongs to a large family of evolution- apo A-I, the major apolipoprotein of with remitting loss of peripheral sen- The Journal of Clinical Investigation | October 1999 | Volume 104 | Number 8 1015 sory and/or motor function. It is not have markedly elevated plasma levels abnormal particles (18) and may be yet known whether different molecu- of LDL-C (mean ∼300 mg/dL), have a associated with symptomatic improve- lar defects in ABC1 are associated with 3- to 4-fold higher risk of premature ment in the peripheral neuropathy each of these mutually exclusive neu- CAD (≤60 years old) than do those (H.H. Hobbs, personal observation). rological subtypes. The major patho- with Tangier disease, who have virtual- The generalized abnormalities among logical findings on peripheral nerve ly no plasma HDL-C (13, 16). Tangier all lipoprotein classes in Tangier dis- biopsy are neuronal loss and lipid patients may have less risk than other- ease illuminate the close link between accumulation in Schwann cells (2). wise expected, because their plasma the metabolism of HDL and the apo The cause of nerve death in this disor- LDL-C levels are also very low (∼40% of B–containing lipoproteins. der is not known, but nerve loss normal, or mean plasma LDL-C ∼50 Therapeutic implications. ABC1 and the appears to precede the development of mg/dL) (2, 14). In epidemiological entire reverse cholesterol transport the lipid-laden Schwann cells (11). studies, individuals with plasma levels pathway present enticing targets for ABC1 may limit the accumulation of of LDL less than ∼80 mg/dL rarely the development of new therapies for toxic substances within neurons by develop CAD (17). Thus, the fact that atherosclerosis. Although reduction of mediating their removal, hence pro- Tangier patients develop CAD to a LDL-C is the crucial factor in reducing viding protection from neuronal cell greater extent than do normal individ- cardiovascular risk, LDL lowering fails injury and death; precedent for such a uals, despite having very low LDL-C to halt the progression of atheroscle- role comes from study of another ABC levels, suggests that
Load more

Recommended publications
  • Some ABCA3 Mutations Elevate ER Stress and Initiate Apoptosis of Lung Epithelial Cells
    Some ABCA3 mutations elevate ER stress and initiate apoptosis of lung epithelial cells Nina Weichert Aus der Kinderklinik und Kinderpoliklinik im Dr. von Haunerschen Kinderspital der Ludwig-Maximilians-Universität München Direktor: Prof. Dr. med. Dr. sci. nat. Christoph Klein Some ABCA3 mutations elevate ER stress and initiate apoptosis of lung epithelial cells Dissertation zum Erwerb des Doktorgrades der Humanmedizin an der Medizinischen Fakultät der Ludwig-Maximilians-Universität zu München Vorgelegt von Nina Weichert aus Heidelberg 2011 Mit Genehmigung der Medizinischen Fakultät der Universität München 1. Berichterstatter: Prof. Dr. Matthias Griese 2. Berichterstatter: Prof. Dr. Dennis Nowak Mitberichterstatter: Priv. Doz. Dr. Angela Abicht Prof. Dr. Michael Schleicher Mitbetreuung durch den promovierten Mitarbeiter: Dr. Suncana Kern Dekan: Herr Prof. Dr. med. Dr. h. c. Maximilian Reiser, FACR, FRCR Tag der mündlichen Prüfung: 24.11.2011 Table of Contents 1.Abstract ................................................................................................................... 1 2.Zusammenfassung................................................................................................. 2 3.Intoduction .............................................................................................................. 3 3.1 Pediatric interstitial lung disease ............................................................................... 3 3.1.1 Epidemiology of pILD..............................................................................................
    [Show full text]
  • Commonly Used Lipidcentric ICD-10 (ICD-9) Codes
    Commonly Used Lipidcentric ICD-10 (ICD-9) Codes *This is not an all inclusive list of ICD-10 codes R.LaForge 11/2015 E78.0 (272.0) Pure hypercholesterolemia E78.3 (272.3) Hyperchylomicronemia (Group A) (Group D) Familial hypercholesterolemia Grütz syndrome Fredrickson Type IIa Chylomicronemia (fasting) (with hyperlipoproteinemia hyperprebetalipoproteinemia) Hyperbetalipoproteinemia Fredrickson type I or V Hyperlipidemia, Group A hyperlipoproteinemia Low-density-lipoid-type [LDL] Lipemia hyperlipoproteinemia Mixed hyperglyceridemia E78.4 (272.4) Other hyperlipidemia E78.1 (272.1) Pure hyperglyceridemia Type 1 Diabetes Mellitus (DM) with (Group B) hyperlipidemia Elevated fasting triglycerides Type 1 DM w diabetic hyperlipidemia Endogenous hyperglyceridemia Familial hyperalphalipoproteinemia Fredrickson Type IV Hyperalphalipoproteinemia, familial hyperlipoproteinemia Hyperlipidemia due to type 1 DM Hyperlipidemia, Group B Hyperprebetalipoproteinemia Hypertriglyceridemia, essential E78.5 (272.5) Hyperlipidemia, unspecified Very-low-density-lipoid-type [VLDL] Complex dyslipidemia hyperlipoproteinemia Elevated fasting lipid profile Elevated lipid profile fasting Hyperlipidemia E78.2 (272.2) Mixed hyperlipidemia (Group C) Hyperlipidemia (high blood fats) Broad- or floating-betalipoproteinemia Hyperlipidemia due to steroid Combined hyperlipidemia NOS Hyperlipidemia due to type 2 diabetes Elevated cholesterol with elevated mellitus triglycerides NEC Fredrickson Type IIb or III hyperlipoproteinemia with E78.6 (272.6)
    [Show full text]
  • Pathology of Tangier Disease
    J Clin Pathol: first published as 10.1136/jcp.24.7.609 on 1 October 1971. Downloaded from J. clin. Path., 1971, 24, 609-616 Pathology of Tangier disease PATRICIA M. BALE, P. CLIFTON-BLIGH, B. N. P. BENJAMIN, AND H. M. WHYTE From the Institute of Pathology, Royal Alexandra Hospital for Children, Camperdown, Sydney, and the Department of Clinical Science, Australian National University, Canberra sYNoPsis Two cases of Tangier disease are described in children from families unrelated to each other. Necropsy in one case, the first to be reported in this condition, showed large collections of cholesterol-laden macrophages in tonsils, thymus, lymph nodes, and colon, and moderate numbers in pyelonephritic scars and ureter. As the storage cells may be scanty in marrow, jejunum, and liver, the rectum is suggested as the site of choice for biopsy. The diagnosis was confirmed by demonstrating the absence of a-lipoproteins from the plasma of the living child, and by finding low plasma levels in both parents of both cases. The disease can be distinguished from other lipidoses by differences in the predominant sites of storage, staining re- actions, and serum lipid studies. Tangier disease is a familial storage disorder in necropsied case. The 12 subjects (Table I) have come which esterified cholesterol accumulates in macro- from eight families, the first of which lived on copyright. phages, while plasma cholesterol is low, and plasma Tangier Island, Chesapeake Bay, Virginia. Males high density lipoprotein is virtually absent. and females have been equally represented, and Ten cases have been reported, and we have studied affected relatives have always oeen siblings, never two additional patients, one of whom is the first parent and child, suggesting an autosomal recessive Received for publication 27 November 1970.
    [Show full text]
  • Mutation of the ABCA1 Gene in Hypoalphalipoproteinemia with Corneal Lipidosis
    4600/366J Hum Genet (2002) 47:366–369 N. Matsuda et al.: © Jpn EGF Soc receptor Hum Genet and osteoblastic and Springer-Verlag differentiation 2002 SHORT COMMUNICATION Jun Ishii · Makoto Nagano · Takeshi Kujiraoka Mitsuaki Ishihara · Tohru Egashira · Daisuke Takada Masahiro Tsuji · Hiroaki Hattori · Mitsuru Emi Clinical variant of Tangier disease in Japan: mutation of the ABCA1 gene in hypoalphalipoproteinemia with corneal lipidosis Received: March 1, 2002 / Accepted: March 15, 2002 Abstract Despite progress in molecular characterization, hypoalphalipoproteinemia syndromes have hampered their specific diagnoses of disorders belonging to a group of in- classification into distinct disease entities. From a clinical herited hypoalphalipoproteinemias, i.e., apolipoprotein AI standpoint, the term “inherited hypoalphalipoproteinemia” deficiency, lecithin-cholesterol acyltransferase deficiency, can apply to apolipoprotein AI (apoAI) deficiency, lecithin- Tangier disease (TD), and familial high-density lipoprotein cholesterol acyltransferase (LCAT) deficiency, Tangier (HDL) deficiency, remain difficult on a purely clinical basis. disease (TD), or so-called familial high-density lipoprotein Several TD patients were recently found to be homozygous (HDL) deficiency (Assmann et al. 1995). Despite some for mutations in the ABCA1 gene. We have documented progress in molecular characterization, specific diagnoses of here a clinical variant of TD in a Japanese patient who these disorders remain difficult because of their phenotypic manifested corneal lipidosis and premature coronary artery spectra overlap and because the penetrance of some symp- disease as well as an almost complete absence of HDL- toms is age related. cholesterol, by identifying a novel homozygous ABCA1 Mutation in ABCA1, a gene mapping to 9q31 and encod- mutation (R1680W). We propose that patients with ap- ing an ATP-binding cassette transporter, confers suscepti- parently isolated HDL deficiency who are found to carry bility to TD, a recessive disease (Bodzioch et al.
    [Show full text]
  • Transient Dyslipidemia Mimicking the Plasma Lipid Profile of Tangier Disease in a Diabetic Patient with Gram Negative Sepsis
    Available online at www.annclinlabsci.org 150 Annals of Clinical & Laboratory Science, vol. 41, no. 2, 2011 Transient Dyslipidemia Mimicking the Plasma Lipid Profile of Tangier Disease in a Diabetic Patient with Gram Negative Sepsis Carlos Palacio, M.D.,1 Irene Alexandraki, M.D.,1 Roger L. Bertholf, Ph.D.,2 and Arshag D. Mooradian, M.D.1 Department of Medicine1 and the Department of Pathology2, University of Florida - College of Medicine, Jacksonville, FL Abstract. Tangier disease is a rare genetic disorder of lipid metabolism characterized by low concentrations of plasma high density lipoprotein (HDL) and low density lipoprotein (LDL) cholesterol with normal or elevated levels of triglycerides. In this case report we describe a patient with diabetes who experienced an episode of urosepsis with a plasma lipid profile resembling Tangier disease. Experimental evidence in the literature suggests that similar lipid changes may occur due to cytokines released during sepsis. Clinicians should be aware of these changes to avoid misdiagnosis of lipid disorders. Introduction Tangier disease during an episode of urosepsis. Within two weeks post recovery the dyslilpidemia Tangier disease (familial alpha lipoprotein resolved and the plasma lipid profile returned to deficiency) is a rare genetic disorder of lipid baseline values. metabolism characterized principally by a severe deficiency of high density lipoprotein (HDL), Clinical History accompanied by low plasma levels of low density lipoprotein (LDL) cholesterol, normal or elevated The patient was a 58-year-old woman presenting plasma levels of triglycerides, and accumulation of with the chief complaint of generalized abdominal cholesteryl ester in reticuloendothelial tissue [1, 2]. pain with nausea, vomiting, and fever for four Phenotypically, patients with Tangier disease may days.
    [Show full text]
  • Download CGT Exome V2.0
    CGT Exome version 2.
    [Show full text]
  • Genetic Dyslipidemia and Cardiovascular Diseases
    Sultan Qaboos University Genetic Dyslipidemia and Cardiovascular Diseases Fahad AL Zadjali, PhD [email protected] We care 1 2/14/18 DISCLOSURE OF CONFLICT No financial relationships with commercial interests 2 2/14/18 Lipoprotein metabolism Genetic diseases: - LDL-cholesterol - HDL-cholesterol - Triglycerides - Combines WHO / Fredrickson classification of primary hyperlipidaemias Familial hypercholestrolemia Genetics defects in ApoB: synthesis and truncated apoB Familial hypobetalipoproteinemia (FHBL) VLDL TG VLDL B MTP & CE lipid B B TG CE ApoB synthesis B TG CE LDL Familial hypobetalipoproteinemia LDL-C very low in homozygotes and fat malabsoprion retinitis pigmentosa Acanthocytosis Heterozygotes have decreased levels of LDL-C and apoB usually asymptomatic and have a decreased risk of CVD Abetalipoproteinemia (ABL): deficiency of MTP - Recessive disorder - Deficiency of all apoB containing lipoproteins (chylomicrons, VLDL and LDL Fat malabsorption Acanthocytosis Retinitis pigmentosa Familial Combined Hypolipidemia - Mutation in Angiopoietin-like protein 3 (ANGPTL3) - increased activity of lipoprotein lipase - Increase clearance of VLDL LDL and HDL - Low TG and low T.Cholesteorl - No evidence of atherosclerosis Defects in HDL cholesterol levels Complete deficiency of HDL: APOAI LCAT ABCA1 Hyperalphalipoproteinemia HL CETP Lecithin:Cholesterol Acyl Transferase Deficiency (LCAT) - Convert cholesterol into cholesterol ester in HDL - deficiency results in accumulation of free cholesterol: corneal opacities Anemia Renal failure Atherosclerosis
    [Show full text]
  • ABCA1) in Human Disease
    International Journal of Molecular Sciences Review The Role of the ATP-Binding Cassette A1 (ABCA1) in Human Disease Leonor Jacobo-Albavera 1,† , Mayra Domínguez-Pérez 1,† , Diana Jhoseline Medina-Leyte 1,2 , Antonia González-Garrido 1 and Teresa Villarreal-Molina 1,* 1 Laboratorio de Genómica de Enfermedades Cardiovasculares, Dirección de Investigación, Instituto Nacional de Medicina Genómica (INMEGEN), Mexico City CP14610, Mexico; [email protected] (L.J.-A.); [email protected] (M.D.-P.); [email protected] (D.J.M.-L.); [email protected] (A.G.-G.) 2 Posgrado en Ciencias Biológicas, Universidad Nacional Autónoma de México (UNAM), Coyoacán, Mexico City CP04510, Mexico * Correspondence: [email protected] † These authors contributed equally to this work. Abstract: Cholesterol homeostasis is essential in normal physiology of all cells. One of several proteins involved in cholesterol homeostasis is the ATP-binding cassette transporter A1 (ABCA1), a transmembrane protein widely expressed in many tissues. One of its main functions is the efflux of intracellular free cholesterol and phospholipids across the plasma membrane to combine with apolipoproteins, mainly apolipoprotein A-I (Apo A-I), forming nascent high-density lipoprotein- cholesterol (HDL-C) particles, the first step of reverse cholesterol transport (RCT). In addition, ABCA1 regulates cholesterol and phospholipid content in the plasma membrane affecting lipid rafts, microparticle (MP) formation and cell signaling. Thus, it is not surprising that impaired ABCA1 function and altered cholesterol homeostasis may affect many different organs and is involved in the Citation: Jacobo-Albavera, L.; pathophysiology of a broad array of diseases. This review describes evidence obtained from animal Domínguez-Pérez, M.; Medina-Leyte, models, human studies and genetic variation explaining how ABCA1 is involved in dyslipidemia, D.J.; González-Garrido, A.; Villarreal- coronary heart disease (CHD), type 2 diabetes (T2D), thrombosis, neurological disorders, age-related Molina, T.
    [Show full text]
  • Dyslipidemia Infosheet 6-10-19
    Genetic Testing for Dyslipidemias Clinical Features: Dyslipidemias are a clinically and genetically heterogenous group of disorders associated with abnormal levels of lipids and lipoproteins, including increased or decreased levels of LDL or HDL cholesterol or increased levels of triglycerides [1]. Dyslipidemias can have a monogenic cause, or may be associated with other conditions such as diabetes and thyroid disease, or lifestyle factors. The most common subset of monogenic dyslipidemia is familial hypercholesterolemia (FH), which has an estimated prevalence of 1 in 200 in the Caucasian population [2]. Our Dyslipidemia Panes includes analysis of all 23 genes listed below. Dyslipidemia Panel Genes ABCA1 APOA1 CETP LDLR LMF1 SAR1B ABCG5 APOA5 GPD1 LDLRAP1 LPL SCARB1 ABCG8 APOB GPIHBP1 LIPA MTTP STAP1 ANGPTL3 APOC2 LCAT LIPC PCSK9 Gene OMIM# Associated disorders Dyslipidemia Inheritance Reference phenotype s ABCA1 60004 Tangier disease; High Low HDL-C Recessive; [3, 4] 6 density lipoprotein (HDL) Dominant deficiency ABCG5 60545 Sitosterolemia Hypercholesterolemia Recessive [5] 9 , hypersitosterolemia ABCG8 60546 Sitosterolemia Hypercholesterolemia Recessive [5] 0 , hypersitosterolemia ANGPTL 60501 Familial Low LDL-C Recessive [6] 3 9 hypobetalipoproteinemia- 2 APOA1 10768 Apolipoprotein A-I Low HDL-C Recessive; [7, 8] 0 deficiency; HDL Dominant deficiency APOA5 60636 Hyperchylomicronemia; Hypertriglyceridemia Dominant/Recessive [9, 10] 8 Hypertriglyceridemia ; Dominant APOB 10773 Familial High LDL-C; Low Co-dominant [1, 11] 0 hypercholesterolemia;
    [Show full text]
  • Studies on the Protein Defect in Tangier Disease
    Studies on the Protein Defect in Tangier Disease ISOLATION AND CHARACTERIZATION OF AN ABNORMAL HIGH DENSITY LIPOPROTEIN SAMUEL E. Lux, ROBERT I. LEVY, ANTONIO M. Gorro, and DONALD S. FREDRICKSON From the Molecular Disease Branch, National Heart and Lung Institute, Bethesda, Maryland 20014 A B S T R A CT High density lipoproteins (d 1.063-1.210 centration of apoLp-Gln-II about 17-fold. The decrease g/ml) were isolated from the plasma of normal indi- in these apoproteins was not due to preferential segrega- viduals (HDL) and seven homozygous patients with tion with the lipoprotein fractions of d < 1.063 g/ml or Tangier disease (HDLT). In Tangier patients., the con- with the plasma proteins of d > 1.21 g/ml. Tangier centration of protein in the high density region (HDLT) apoLp-Gln-I and apoLp-Gln-II appeared to be immuno- was only 0.5-4.5% of normal. Immunochemical studies, chemically identical with their normal counterparts, and including mixing experiments conducted in vivo and in no differences between the two sets of apoproteins were vitro, indicated that HDLT was different from HDL. detected on polyacrylamide gel electrophoresis at pH HDLT was the only high density lipoprotein detectable 9.4 or 2.9. These results are most compatible with the in the plasma of Tangier homozygotes. In heterozygotes hypothesis that the hereditary defect in Tangier disease both HDL and HDLT were present. HDLT was not de- is a mutation in an allele-regulating synthesis of tected in the plasma of over 300 normal persons and apoLp-Gln-I.
    [Show full text]
  • Whole Exome Sequencing Gene Package Metabolic Disorders, Version 5.1, 31-1-2020
    Whole Exome Sequencing Gene package Metabolic disorders, version 5.1, 31-1-2020 Technical information DNA was enriched using Agilent SureSelect DNA + SureSelect OneSeq 300kb CNV Backbone + Human All Exon V7 capture and paired-end sequenced on the Illumina platform (outsourced). The aim is to obtain 10 Giga base pairs per exome with a mapped fraction of 0.99. The average coverage of the exome is ~50x. Duplicate and non-unique reads are excluded. Data are demultiplexed with bcl2fastq Conversion Software from Illumina. Reads are mapped to the genome using the BWA-MEM algorithm (reference: http://bio-bwa.sourceforge.net/). Variant detection is performed by the Genome Analysis Toolkit HaplotypeCaller (reference: http://www.broadinstitute.org/gatk/). The detected variants are filtered and annotated with Cartagenia software and classified with Alamut Visual. It is not excluded that pathogenic mutations are being missed using this technology. At this moment, there is not enough information about the sensitivity of this technique with respect to the detection of deletions and duplications of more than 5 nucleotides and of somatic mosaic mutations (all types of sequence changes). HGNC approved Phenotype description including OMIM phenotype ID(s) OMIM median depth % covered % covered % covered gene symbol gene ID >10x >20x >30x AASS Hyperlysinemia, 238700 605113 63 100 97 90 Saccharopinuria, 268700 ABAT GABA-transaminase deficiency, 613163 137150 100 100 100 96 ABCA1 HDL deficiency, familial, 1, 604091 600046 92 100 100 97 Tangier disease, 205400
    [Show full text]
  • Tangier Disease)
    The Inheritance of High Density Lipoprotein Deficiency (Tangier Disease) Donald S. Fredrickson J Clin Invest. 1964;43(2):228-236. https://doi.org/10.1172/JCI104907. Research Article Find the latest version: https://jci.me/104907/pdf Journal of Clinical Investigation Vol. 43, No. 2, 1964 The Inheritance of High Density Lipoprotein Deficiency (Tangier Disease) * DONALD S. FREDRICKSON WITH THE TECHNICAL ASSISTANCE OF OSCAR YOUNG, TATSUJI SHIRATORI, AND NANCI BRIGGS (From the National Heart Institute, Bethesda, Md.) A familial syndrome consisting of complete or close relatives, including parents, grandparents, great- nearly complete absence of plasma high density grandparents, and the sibs and offspring of these and 2) the remainder, termed "distant" relatives, including lipoprotein (HDL) associated with storage of 90 subj ects. Many of these subjects were originally cholesterol esters in reticuloendothelial tissues has selected to serve as unrelated community controls. As been previously reported ( 1, 2). It has been pedigree information was gradually assembled, however, given the name Tangier disease after the com- only 17 could not be proved to have at least one rela- munity of origin of the first two cases. Its prom- tive common to the T propositi. Tangier Island was settled in the 17th century and inent clinical features include hypocholesterolemia, has had a stable population of about 900 for many tonsils of unusual size and coloration, and, some- generations. The original settlers were Anglo-Saxon, times, hepatosplenomegaly and lymphadenopathy. and all of the names of subjects studied suggest origin Three pairs of sibs with the full-blown syn- from the British Isles. There are no written records drome have been discovered in three different on the island from which comprehensive pedigree in- (1, 3, 4).
    [Show full text]